Vaishali Pharma Ltd
VAISHALIVaishali Pharma Ltd
VAISHALI![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/high_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
274.27 | 4.94 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 69.89 | 64.90 | 69.42 | 77.07 | 62.26 | 55.58 | 77.61 | 71.89 | 88.31 | 88.31 | ||||||||||
Raw Materials | 62.07 | 53.94 | 60.61 | 67.78 | 50.99 | 45.86 | 63.54 | 57.10 | 85.14 | 85.14 | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Employee Cost | 1.56 | 1.59 | 2.04 | 2.13 | 1.27 | 1.19 | 1.36 | 1.30 | ||||||||||||
Selling & Administrative Expenses | 0.00 | 2.38 | 2.97 | 2.15 | 2.62 | 1.94 | 4.06 | 4.28 | ||||||||||||
Operating & Other expenses | 2.53 | 2.59 | -0.65 | 0.96 | 4.31 | 2.13 | -0.03 | -2.39 | ||||||||||||
EBITDA | 3.73 | 4.40 | 4.45 | 4.05 | 3.07 | 4.46 | 8.68 | 11.60 | 3.17 | 3.17 | ||||||||||
Depreciation/Amortization | 0.37 | 0.28 | 0.25 | 0.27 | 0.44 | 0.43 | 0.46 | 0.50 | 0.51 | 0.50 | ||||||||||
PBIT | 3.36 | 4.12 | 4.20 | 3.78 | 2.63 | 4.03 | 8.22 | 11.10 | 2.66 | 2.67 | ||||||||||
Interest & Other Items | 3.37 | 3.10 | 2.85 | 2.66 | 2.56 | 2.63 | 2.49 | 2.26 | 1.74 | 1.73 | ||||||||||
PBT | -0.01 | 1.02 | 1.35 | 1.12 | 0.07 | 1.40 | 5.73 | 8.84 | 0.92 | 0.94 | ||||||||||
Taxes & Other Items | 0.03 | 0.33 | 0.55 | 0.42 | 0.05 | 0.36 | 1.70 | 2.24 | 0.21 | 0.21 | ||||||||||
Net Income | -0.04 | 0.69 | 0.80 | 0.70 | 0.02 | 1.04 | 4.03 | 6.60 | 0.71 | 0.73 | ||||||||||
EPS | -0.05 | 0.90 | 0.65 | 0.41 | 0.01 | 0.99 | 3.82 | 6.26 | 0.67 | 0.69 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Investor Presentation
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Vaishali Pharma Ltd | 282.00 | 4.94 | — |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare VAISHALI with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 1.74%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 2.04%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
May 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
VAISHALI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Stocks that will see action on March 2, 2023
![](https://pocket-image-cache.com/direct?url=http://bl-i.thgim.com/public/news/3oaq5g/article66570470.ece/alternates/LANDSCAPE_1200/stock.jpg)
Vaishali Pharma bags orders worth Rs 600 crore for purchase of antibiotic products
Vaishali Pharma standalone net profit rises 65.22% in the December 2022 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Stock market update: Stocks that hit 52-week highs on NSE in today’s trade
![](https://pocket-image-cache.com/direct?url=http://img.etimg.com/thumb/msid-83745691,width-1070,height-580,imgsize-156851,overlay-etmarkets/photo.jpg)
Vaishali Pharma standalone net profit rises 42.14% in the September 2022 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Sankalp Life Care ropes in Vaishali Pharma to market nutraceutical products
Vaishali Pharma Standalone December 2021 Net Sales At Rs 22.28 Crore, Up 4.63% Y-o-Y
![](https://pocket-image-cache.com/direct?url=http://images.moneycontrol.com/static-mcnews/2017/04/shutterstock_310523045-462x435.jpg)
Vaishali Pharma standalone net profit declines 6.40% in the December 2021 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Vaishali Pharma standalone net profit rises 81.82% in the September 2021 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Vaishali Pharma reports standalone net profit of Rs 0.81 crore in the June 2021 quarter
![](https://assets.tickertape.in/images/news-publishers/businessstandard.png)
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2.76%, vs industry avg of 8.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.03% to 0.02%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 0.28%, vs industry avg of 15.15%